Table 3. Factors Associated With Herpes Zoster Vaccination
All(N = 403)HZ Vaccination(n = 31)No HZ Vaccination(n = 372)Odds Ratio(95% CI)
Age (years)72.874.4 ± 9.372.6 ± 8.9
    60–6489 (22.1)5 (16.1)84 (22.5)1.0*
    ≥65312 (77.4)26 (83.8)286 (76.8)1.53 (0.57–4.1)
Race, n (%)
    African American198 (49)4 (2)194 (98)1.0*
    White191 (47)26 (14)165 (86)3.4 (1.03–11.1)
Education (years)11 ± 3.213.7 ± 3.011 ± 3.2
    <12160 (39.7)3 (2)157 (98)1.0*
    ≥12215 (53.3)23 (11)192 (89)4.6 (1.3–6.2)
Race and education interaction
    AAs with <high school104 (25.8)2 (2)102 (98)1.0*
    Whites with ≥high school118 (29.2)20 (16.9)98 (83)6.7 (1.4–31.0)
History of shingles48 (11.9)4 (12.9)44 (11.8)1.1 (0.37–3.27)
Witnessed someone with shingles212 (53)25 (81)*187 (51)4.1 (1.6–10.2)
Received influenza vaccine in the past357 (89)30 (97)327 (88)4.1 (0.55–31.0)
Clinic Site
    Internal medicine clinic134 (33)13 (42)121 (33)1.0*
    Family medicine clinic133 (33)6 (19)127 (34)0.44 (0.16–1.19)
    Geriatric clinic134 (33)12 (39)122 (33)0.92 (0.4–2.1)
  • Values provided as n (%). Values may not add to 100 percent due to some subjects declining to answer some parts of the survey.

  • * Reference group for comparison.

  • Multivariate logistic regression analysis controlling for effects of age, sex, race, education, and having seen someone with shingles.

  • HZ = Herpes Zoster; AAs = African Americans.